Cargando…

Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study

BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of uretero...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalatharan, Vinusha, Welk, Blayne, Nash, Danielle M., McArthur, Eric, Slater, Justin, Sarma, Sisira, Pei, York, Garg, Amit X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691941/
https://www.ncbi.nlm.nih.gov/pubmed/33282326
http://dx.doi.org/10.1177/2054358120972830
_version_ 1783614400733642752
author Kalatharan, Vinusha
Welk, Blayne
Nash, Danielle M.
McArthur, Eric
Slater, Justin
Sarma, Sisira
Pei, York
Garg, Amit X.
author_facet Kalatharan, Vinusha
Welk, Blayne
Nash, Danielle M.
McArthur, Eric
Slater, Justin
Sarma, Sisira
Pei, York
Garg, Amit X.
author_sort Kalatharan, Vinusha
collection PubMed
description BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of ureteroscopic complications between patients with and without ADPKD. DESIGN: Retrospective cohort study. SETTING: Ontario, Canada PATIENTS: Seventy three patients with ADPKD and 81 445 patients without ADPKD who underwent ureteroscopy for upper urinary tract stones between April 1, 2002, and March 1, 2018. MEASUREMENTS: A 30-day risk of (1) hospital presentation with ureteroscopic complications (which was a composite outcome of either emergency department visit or hospital admission with acute kidney injury, urinary tract infection, or sepsis); (2) all-cause hospital presentation; (3) all-cause hospital admission; and (4) all-cause emergency department visit. METHODS: We regressed outcomes on demographic variables, health care use in the prior 1-year, various procedures and comorbidities related to the outcome in the prior 5 years, and prescribed medications filled in the past 120 days using modified Poisson regression to compare the risk ratio (RR) of each outcome between patients with and without ADPKD. RESULTS: The median (interquartile, IQR) age was 44 (38-60 years) in the ADPKD group and 53 (42-64) in the control group. About 40% were women in both groups. The risk of ureteroscopic complications was not significantly different in patients with versus without ADPKD (8.2% vs 4.3%; adjusted RR = 1.5, 95% confidence interval [CI] = 0.7-3.2). Patients with versus without ADPKD were more likely to present to hospital after their procedure (35.6% vs. 20.0%; adjusted RR = 1.6, 95% CI = 1.2-2.2), which included a statistically significant increase in the risk of presenting to the emergency department (32.9% vs. 19.0%; adjusted RR = 1.6, 95% CI = 1.1-2.2) but not hospital admissions (10.9% vs. 5.0%; adjusted RR = 1.8, 95% CI = 0.9-3.4). LIMITATIONS: The low numbers of events led to imprecision around the estimates. CONCLUSION: Patients with ADPKD have a higher risk of return to the hospital within 30 days of ureteroscopy for stone disease. TRIAL REGISTRATION: We did not register this study.
format Online
Article
Text
id pubmed-7691941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-76919412020-12-04 Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study Kalatharan, Vinusha Welk, Blayne Nash, Danielle M. McArthur, Eric Slater, Justin Sarma, Sisira Pei, York Garg, Amit X. Can J Kidney Health Dis Original Clinical Research Quantitative BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of ureteroscopic complications between patients with and without ADPKD. DESIGN: Retrospective cohort study. SETTING: Ontario, Canada PATIENTS: Seventy three patients with ADPKD and 81 445 patients without ADPKD who underwent ureteroscopy for upper urinary tract stones between April 1, 2002, and March 1, 2018. MEASUREMENTS: A 30-day risk of (1) hospital presentation with ureteroscopic complications (which was a composite outcome of either emergency department visit or hospital admission with acute kidney injury, urinary tract infection, or sepsis); (2) all-cause hospital presentation; (3) all-cause hospital admission; and (4) all-cause emergency department visit. METHODS: We regressed outcomes on demographic variables, health care use in the prior 1-year, various procedures and comorbidities related to the outcome in the prior 5 years, and prescribed medications filled in the past 120 days using modified Poisson regression to compare the risk ratio (RR) of each outcome between patients with and without ADPKD. RESULTS: The median (interquartile, IQR) age was 44 (38-60 years) in the ADPKD group and 53 (42-64) in the control group. About 40% were women in both groups. The risk of ureteroscopic complications was not significantly different in patients with versus without ADPKD (8.2% vs 4.3%; adjusted RR = 1.5, 95% confidence interval [CI] = 0.7-3.2). Patients with versus without ADPKD were more likely to present to hospital after their procedure (35.6% vs. 20.0%; adjusted RR = 1.6, 95% CI = 1.2-2.2), which included a statistically significant increase in the risk of presenting to the emergency department (32.9% vs. 19.0%; adjusted RR = 1.6, 95% CI = 1.1-2.2) but not hospital admissions (10.9% vs. 5.0%; adjusted RR = 1.8, 95% CI = 0.9-3.4). LIMITATIONS: The low numbers of events led to imprecision around the estimates. CONCLUSION: Patients with ADPKD have a higher risk of return to the hospital within 30 days of ureteroscopy for stone disease. TRIAL REGISTRATION: We did not register this study. SAGE Publications 2020-11-24 /pmc/articles/PMC7691941/ /pubmed/33282326 http://dx.doi.org/10.1177/2054358120972830 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Clinical Research Quantitative
Kalatharan, Vinusha
Welk, Blayne
Nash, Danielle M.
McArthur, Eric
Slater, Justin
Sarma, Sisira
Pei, York
Garg, Amit X.
Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title_full Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title_fullStr Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title_full_unstemmed Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title_short Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
title_sort complications in patients with autosomal dominant polycystic kidney disease undergoing ureteroscopy: a cohort study
topic Original Clinical Research Quantitative
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691941/
https://www.ncbi.nlm.nih.gov/pubmed/33282326
http://dx.doi.org/10.1177/2054358120972830
work_keys_str_mv AT kalatharanvinusha complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT welkblayne complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT nashdaniellem complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT mcarthureric complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT slaterjustin complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT sarmasisira complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT peiyork complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy
AT gargamitx complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy